1. Handbook
  2. Subjects
  3. Animal Physiology and Growth
  4. Eligibility and requirements

Animal Physiology and Growth (DASC20010) // Eligibility and requirements

You’re viewing the 2017 Handbook:
Or view archived Handbooks
You’re currently viewing the 2017 version of this subject

Eligibility and requirements

Prerequisites

Students must have completed one of the following:

Code Name Teaching period Credit Points
BIOL10002 Biomolecules and Cells
Semester 1 (On Campus - Parkville)
 12.5
BIOL10004 Biology of Cells and Organisms
Semester 1 (On Campus - Parkville)
 12.5

Corequisites

None

Non-allowed subjects

None

Inherent requirements (core participation requirements)

Q Fever: Students enrolling in this subject are advised that some courses of study may put them at an increased risk of contracting Q Fever. Q Fever is a relatively common preventable condition which, while rarely fatal, can cause a severe acute illness and can result in damage to heart valves and chronic fatigue. It is recommended that students consider undertaking screening and vaccination for Q Fever prior to commencement of study. Students may be required to provide proof of vaccination prior to undertaking some coursework. Vaccine costs for students are not covered by the Pharmaceutical Benefit Scheme, Medicare, or by the University. Some students with full private medical coverage (which has hospital and ancillary cover) may receive partial re-imbursement for vaccine costs.

The University of Melbourne is committed to providing students with reasonable adjustments to assessment and participation under the Disability Standards for Education (2005), and the Assessment and Results Policy (MPF1326). Students are expected to meet the core participation requirements for their course. These can be viewed under Entry and Participation Requirements for the course outlines in the Handbook.

Further details on how to seek academic adjustments can be found on the Student Equity and Disability Support website: http://services.unimelb.edu.au/student-equity/home

Last updated: 9 April 2025